La. Woman Says Weight Loss Drug Belviq Caused Breast Cancer



DOCUMENTS
  • Complaint


NEW ORLEANS — A Louisiana woman has sued EISAI Inc. and Arena Pharmaceuticals in federal court, alleging that her use of the weight loss drug Belviq (lorcaserin hydrochloride) caused her to develop breast cancer.

In a June 10 complaint filed in the U.S. District Court for the Eastern District of Louisiana, Stephanie Fuller and her husband accuses EISAI and Arena of failing to perform sufficient tests, if any, on humans during clinical trials, forcing plaintiff and her doctors to rely on safety information that applies to other chronic weight management treatments, but not necessarily Belviq.

“Defendants concealed their knowledge of …

FIRM NAMES
  • Cossich Sumich Parisola & Taylor
  • Douglas & London





UPCOMING CONFERENCES




HarrisMartin's Webinar Series: The Paragard IUD Litigation

November 10, 2020 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin's Webinar Series: TDF HIV Litigation

November 11, 2020 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS